|
Beyond ganglion cells: Novel foveal avascular zone features in MS with implications for vision loss |
1R01EY033475-01A1 |
|
NEI |
2022 |
|
Identification of a novel pathway that regulates optic nerve myelination and remyelination |
3R00EY029330-05S1 |
|
NEI |
2022 |
|
Developing Remyelination Strategies for Demyelinating Optic Neuropathies Using Human Pluripotent Stem Cells |
4R00EY029011-03 |
|
NEI |
2022 |
|
Molecular Mechanisms of Diabetic Retinal Ganglion Cell Dysfunction and Neurovascular Crosstalk in Early Diabetic Retinopathy |
5K08EY029766-04 |
|
NEI |
2022 |
|
Identification of a novel pathway that regulates optic nerve myelination and remyelination |
5R00EY029330-05 |
|
NEI |
2022 |
|
Molecular Mechanism of the Parkinsons Disease-associated protein LRRK2 |
1R01AG075132-01A1 |
|
NIA |
2022 |
|
Developing a Prediction Model to Improve End‐of‐Life Prognostication and Hospice Referral in Parkinsons Disease |
1R21AG075524-01A1 |
|
NIA |
2022 |
|
Astrocyte NLRP3 inflammasome activation in Parkinsons disease |
5F30AG067643-03 |
|
NIA |
2022 |
|
Feasibility of Objective Measures and Outpatient Washout in Disease-Modifying Trials for Parkinsons Disease |
5K01AG066971-02 |
|
NIA |
2022 |
|
Mechanisms Underlying Improved Health Span on a Short-Term Ketogenic Diet |
5P01AG062817-04 |
|
NIA |
2022 |